Sun, H., Liu, S., Zhou, J., Xu, J., Zhang, H., Yan, H., . . . Wu, Y. (2020, October). Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma. EBioMedicine.
Chicagoスタイル(17版)引用形式Sun, Hao, et al. "Specific TP53 Subtype as Biomarker for Immune Checkpoint Inhibitors in Lung Adenocarcinoma." EBioMedicine Oct. 2020.
MLA(9版)引用形式Sun, Hao, et al. "Specific TP53 Subtype as Biomarker for Immune Checkpoint Inhibitors in Lung Adenocarcinoma." EBioMedicine, Oct. 2020.
警告: この引用は必ずしも正確ではありません.